Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2009
12/10/2009WO2008103971A3 Prostate cancer survival and recurrence
12/10/2009WO2008088857A3 Methods and compositions for detecting receptor-ligand interactions in single cells
12/10/2009WO2005075663A3 Nanosized composite material containing a biological compound and process for the preparation
12/10/2009US20090307806 Genetic markers for high oleic acid content in plants
12/10/2009US20090307804 Transcription Regulating Nucleotide Sequence from Solanaceae Triose-Phosphate Translocator Genes and Their Use in Plant Expression Cassettes
12/10/2009US20090307798 Polynucleotides and Methods for Making Plants Resistant to Fungal Pathogens
12/10/2009US20090307791 Calcium-activated chloride channel and methods of use thereof
12/10/2009US20090307790 Isolation of the t-complex distorters and applications thereof
12/10/2009US20090307180 Genetic analysis
12/10/2009US20090306360 2-azaadenine bases form specific base pairs with guanine; when used to substitute cytosine in oligonucleotides leads specifically to hybridization complexes with nucleic acids with homogenous stability; 3-(2-Deoxy- beta -D-erythro-pentofuranosyl)-3H-imidazo[2,1-i]purine (1,N6-Etheno-2'-deoxyadenosine, 5)
12/10/2009US20090306230 High Throughput Testing for Presence of Microorganisms in a Biological Sample
12/10/2009US20090306192 BAG3 nucleotide and protein sequences to be used in research, diagnostics and therapy for cell death-involving diseases, and for modulation of cell survival and/or death
12/10/2009US20090306186 Novel tissue protective erythropoietin receptor (nepor) and methods of use
12/10/2009US20090306185 Nanogenomics for medicine: siRNA engineering
12/10/2009US20090306183 Compositions and Methods for the Treatment of Diseases Associated with Aberrant Cilia Assembly and Regulation
12/10/2009US20090306181 Compositions and methods for evaluating and treating heart failure
12/10/2009US20090306131 Cell lines with latent immunodeficiency virus and methods of use thereof
12/10/2009US20090306099 Monitoring human response to antiviral agents; obtain tissue sample, extract nucleotide sequences, detect tumor necrosis factor genotype, presence of genotype indicates sensitivity to viricide; treating a male Caucasian human in need of treatment with abacavir
12/10/2009US20090306094 Pharmacogenetics around BCR-ABL individuals with drug bosutinib; determining if they will have drug resistance
12/10/2009US20090306036 Methods of screening agents, conjugates or conjugate moieties for transport by a pept2 transporter
12/10/2009US20090306035 Compounds and Methods for modulating the Silencing of a Polynucleotide of Interest
12/10/2009US20090306000 Tanaproget derivatives, metabolites, and uses thereof
12/10/2009US20090305991 33 Human Secreted Proteins
12/10/2009US20090305980 Methods and Compositions Related to TR4
12/10/2009US20090305972 Novel cancer-associated antigen
12/10/2009US20090305971 Nogo-B Receptor
12/10/2009US20090305963 Lipocalin 2 for the Treatment, Prevention, and Management of Cancer Metastasis, Angiogenesis, and Fibrosis
12/10/2009US20090305904 Apoptosis modulator bcl-b and methods for making and using same
12/10/2009US20090305903 Methods and compositions for diagnosis, monitoring and development of therapeutics for treatment of atherosclerotic disease
12/10/2009US20090305900 Genemap of the human genes associated with longevity
12/10/2009US20090305433 Water-Soluble Rhodamine Dye Conjugates
12/10/2009US20090305422 Methods and reagents for preservation of dna in bodily fluids
12/10/2009US20090305405 Use of tgf beta superfamily antagonists and neurotrophins to make neurons from embryonic stem cells
12/10/2009US20090305383 Early Detection of Pathogens in Blood
12/10/2009US20090305336 Devices and methods for sampling microbial flora
12/10/2009US20090305335 Method for analysing a sample
12/10/2009US20090305334 Method for making a biological indicator for use with vaporous microbial deactivating agents
12/10/2009US20090305333 Promoting Axon Regeneration in the Adult CNS through Control of Protein Translation
12/10/2009US20090305332 Method and Apparatus for Determining an Analyte in a Liquid Sample
12/10/2009US20090305331 Kits and methods for determining colon cleanliness
12/10/2009US20090305330 Method and apparatus for the detection of living phytoplankton cells in water
12/10/2009US20090305329 Intracellular targeting of molecules
12/10/2009US20090305328 Method of improvement of organisms using profiling the flux sum of metabolites
12/10/2009US20090305327 Mass Spectrometric Determination Of Blood Enzyme Activity
12/10/2009US20090305326 Microfluidic device and method for coupling discrete microchannels and for co-culture
12/10/2009US20090305325 Method for Preservation of Human Hematopoietic Stem or Progenitor Cells
12/10/2009US20090305324 Cytotoxic t-cell epitope peptides that specifically attack epstein-barr virus-infected cells and uses thereof
12/10/2009US20090305323 Lipidomics approaches for central nervous system disorders
12/10/2009US20090305322 Isotope Detection and Uses Thereof
12/10/2009US20090305321 Assays for Allosteric Modulators of G-Protein Coupled Receptors (GPCRs)
12/10/2009US20090305320 Method of detecting activation of notch signal transmission system
12/10/2009US20090305319 Apparatus and methods for monitoring the status of a metabolically active cell
12/10/2009US20090305318 Diagnostic Tests of Substance Use Disorders
12/10/2009US20090305317 User interface for testing device
12/10/2009US20090305316 mutant protein of PQQ-dependent s-GDH (glucose dehydrogenase) with the A. calcoaceticus s-GDH wild-type sequence; for measurement of glucose, especially by a tests strip device or with a biosensor
12/10/2009US20090305315 Hubbed dual cannula device for closed container sampling systems
12/10/2009US20090305311 C4d/c4b standard for quantitative flow cytometry of humoral transplant rejection
12/10/2009US20090305308 Method for identifying cell-specific protein combination patterns
12/10/2009US20090305306 Lectin Complement Pathway Assays and Related Compositions and Methods
12/10/2009US20090305301 Detection of venous thromboembolic diseases by measurement of d-dimers and soluble fibrin levels
12/10/2009US20090305296 Test kit for detecting periodontal disease
12/10/2009US20090305295 Identification of a gene expression profile that differentiates ischemic and nonischemic cardiomyopathy
12/10/2009US20090305294 Method of isolating nucleic acids from stool samples
12/10/2009US20090305293 Molecular biology; probe to given sequence; detection of this fungi in a sample
12/10/2009US20090305292 Dna polymerase
12/10/2009US20090305291 method and a microdevice for the identification and/or quantification of an analyte in a biological sample
12/10/2009US20090305290 Lateral flow nucleic acid detector
12/10/2009US20090305289 Screening method to identify protective substances for the treatment of neurodegenerative and/or ischaemic diseases
12/10/2009US20090305288 Methods for amplifying nucleic acids and for analyzing nucleic acids therewith
12/10/2009US20090305287 Method and System for Multiplex Genetic Analysis
12/10/2009US20090305286 Method for the Identification of Suitable Fragmentation Sites in a Reporter Protein
12/10/2009US20090305285 Asymmetric cyanine compounds, their preparation methods and their uses
12/10/2009US20090305284 Methods for Identifying Risk of Breast Cancer and Treatments Thereof
12/10/2009US20090305283 thermostable FEN-1 endonuclease and a polymerase; site-specific nuclease cleavage by a variety of enzymes
12/10/2009US20090305282 Novel human virus causing respiratory tract infection and uses thereof
12/10/2009US20090305281 Novel inhibitors of retroviral reverse transcriptace
12/10/2009US20090305280 Luciferase biosensors for camp
12/10/2009US20090305279 Method of diagnosis
12/10/2009US20090305278 Sequence determination in confined regions
12/10/2009US20090305277 Gene expression markers for prediction of patient response to chemotherapy
12/10/2009US20090305276 Method for Predicting Skin Sensitizing Activity of Compounds
12/10/2009US20090305275 DNAs AND PROTEINS OR PEPTIDES SPECIFIC TO BACTERIA OF THE SPECIES NEISSERIA MENINGITIDIS, PROCESS FOR OBTAINING THEM AND THEIR BIOLOGICAL USES
12/10/2009US20090305274 Method for determining azole resistance in candida glabrata
12/10/2009US20090305273 Nanonozzle device arrays: their preparation and use for macromolecular analysis
12/10/2009US20090305272 Method of characterizing endogenous polynucleotide-polypeptide interactions
12/10/2009US20090305271 In Vitro Assay Based on Camp Levels Modulated by Gi-Coupled Receptors
12/10/2009US20090305270 Antigenic surface structure of sperm cells associated with the y chromosome
12/10/2009US20090305269 Pcr screening method
12/10/2009US20090305268 Method of determining an amount of fatty acid contents in bovine intramuscular fat on the basis of genotype of fatty acid synthase gene and method of determining goodness of eating quality of beef on the basis of the results thereof
12/10/2009US20090305267 Microbial markers of inflammatory bowel disease
12/10/2009US20090305266 Test for ovarian cancer by detecting abnormality in fancd2 pathway
12/10/2009US20090305265 Interleukin-33 (il-33) for the diagnosis and prognosis of cardiovascular disease
12/10/2009US20090305264 Cooperative probes and methods of using them
12/10/2009US20090305263 Probe, probe set, probe-immobilized carrier, and genetic testing method
12/10/2009US20090305262 Probe, probe set, probe-immobilized carrier, and genetic testing method
12/10/2009US20090305261 Probe, probe set, probe-immobilized carrier, and genetic testing method
12/10/2009US20090305260 Probe, probe set, probe-immobilized carrier, and genetic testing method
12/10/2009US20090305259 Early Diagnosis of Congenital Abnormalities in the Offspring of Diabetic Mothers
12/10/2009US20090305258 Methods for the diagnosis of proliferative and/or conformational diseases
12/10/2009US20090305257 Biomarkers downregulated in prostate cancer